• 69 Citations
  • 4 h-Index
20122019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hoda Yeganehjoo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 69 Citations
  • 4 h-Index
  • 5 Article
  • 2 Review article
  • 1 Chapter

The potential of isoprenoids in adjuvant cancer therapy to reduce adverse effects of statins

Mo, H., Jeter, R., Bachmann, A., Yount, S. T., Shen, C. L. & Yeganehjoo, H., Jan 1 2019, In : Frontiers in Pharmacology. 9, JAN, 1515.

Research output: Contribution to journalReview article

Open Access
  • 4 Scopus citations

    The stimulatory impact of d-δ-Tocotrienol on the differentiation of murine MC3T3-E1 preosteoblasts

    Shah, A. K. & Yeganehjoo, H., Dec 1 2019, In : Molecular and Cellular Biochemistry. 462, 1-2, p. 173-183 11 p.

    Research output: Contribution to journalArticle

  • Synergistic Impact of d-δ-Tocotrienol and Geranylgeraniol on the Growth and HMG CoA Reductase of Human DU145 Prostate Carcinoma Cells

    Yeganehjoo, H., DeBose-Boyd, R., McFarlin, B. K. & Mo, H., Mar 29 2017, (Accepted/In press) In : Nutrition and Cancer. p. 1-10 10 p.

    Research output: Contribution to journalArticle

  • 10 Scopus citations
  • 3 Scopus citations

    Geranylgeraniol suppresses the viability of human DU145 prostate carcinoma cells and the level of HMG CoA reductase

    Fernandes, N. V., Yeganehjoo, H., Katuru, R., DeBose-Boyd, R. A., Morris, L. L., Michon, R., Yu, Z. L. & Mo, H., Nov 2013, In : Experimental Biology and Medicine. 238, 11, p. 1265-1274 10 p.

    Research output: Contribution to journalArticle

  • 9 Scopus citations